Q
QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

24,197 signal articles · 275 in last 24h · 114,878 total before filter · latest 28m ago
275last 24h
1875last 7d
299● bullish (7d)
166● bearish (7d)
205publishers
AllMacro321Earnings929M&A99Regulatory21Product17Analyst23
✕ clear all filtersticker: ^GSPCSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
StockStory74d agobullish
1 Energy Stock on Our Buy List and 2 Facing Headwinds

Energy businesses quietly power the physical things we depend on, from cars and homes to e-commerce infrastructure. But their prominence also brings high exposure to the ups and downs of economic and energy cycles. Luckily, the tide is turning in their favor as the industry’s 29% return over the past six months has topped the S&P 500 by 18.1 percentage points.

Analyst Says Dell’s Momentum Is Real, But Valuation Is Risky with Stock Up 250% YTD
24/7 Wall St.74d agoneutral
Analyst Says Dell’s Momentum Is Real, But Valuation Is Risky with Stock Up 250% YTD

Dell Technologies (NYSE:DELL) has become one of the market’s biggest AI winners. The stock has rocketed over 250% year to date and more than 100% in the past month alone, fueled by explosive demand for AI infrastructure. Yet even some bulls are beginning to question how much future growth is already reflected in the share ... Analyst Says Dell’s Momentum Is Real, But Valuation Is Risky with Stock Up 250% YTD

The AI boom could be heading to millions of 401(k)s as Anthropic files for IPO
Washington Post74d agoneutral
The AI boom could be heading to millions of 401(k)s as Anthropic files for IPO

Anthropic, maker of the chatbot Claude, said Monday that it had filed confidential paperwork with federal regulators in preparation for selling its stock to the public. The company is expected to be one of three trillion-dollar debuts on the stock market this year, along with Elon Musk’s rocket and AI venture SpaceX and OpenAI, maker of ChatGPT. SpaceX filed to go public in April and OpenAI is expected to do so soon. (The Washington Post has a content partnership with OpenAI.)Subscribe to The Po

There's risk in AI concentration, but stock prices are 'justified'
Yahoo Finance Video74d agoneutralVIDEO
There's risk in AI concentration, but stock prices are 'justified'

June is finally here and US stocks (^DJI, ^IXIC, ^GSPC) are feeling awfully festive, all three of the major indexes notching new records in the first trading day of the month. Nomura Asset Management chief investment strategist Andy Goldberg looks at why the market's biggest movers are still so concentrated within the AI trade and whether these stock prices are justified.

What the S&P 500 would look like without AI leaders
Yahoo Finance Video74d agoneutralVIDEO
What the S&P 500 would look like without AI leaders

Yahoo Finance Markets and Data Editor Jared Blikre takes a closer look at how the S&P 500 (^GSPC) is performing both with and without leading AI stocks, noting major market events like the ongoing US-Iran war.

3 Reasons to Avoid TRN and 1 Stock to Buy Instead
StockStory74d agobullish
3 Reasons to Avoid TRN and 1 Stock to Buy Instead

Trinity’s 22.9% return over the past six months has outpaced the S&P 500 by 11.9%, and its stock price has climbed to $32.41 per share. This performance may have investors wondering how to approach the situation.

3 Reasons to Avoid HIG and 1 Stock to Buy Instead
StockStory74d agobullish
3 Reasons to Avoid HIG and 1 Stock to Buy Instead

Over the past six months, Hartford’s shares (currently trading at $127.05) have posted a disappointing 6.2% loss, well below the S&P 500’s 10.9% gain. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.

3 Reasons to Sell CLX and 1 Stock to Buy Instead
StockStory74d agoneutral
3 Reasons to Sell CLX and 1 Stock to Buy Instead

Over the last six months, Clorox’s shares have sunk to $90.24, producing a disappointing 15.2% loss - a stark contrast to the S&P 500’s 10.9% gain. This might have investors contemplating their next move.

U.S. Health Care Depth or Global Industry Reach? VHT vs. IXJ
Motley Fool74d agoneutral
U.S. Health Care Depth or Global Industry Reach? VHT vs. IXJ

The Vanguard Health Care ETF (VHT) and the iShares Global Healthcare ETF (IXJ) both target health care stocks, but they are tailored to different investor needs. One emphasizes broad, low-cost U.S. exposure, while the other adds global reach in a sector shaped by drug pricing, patent cycles, regulation, and medical innovation.

B&G Foods (BGS): Buy, Sell, or Hold Post Q1 Earnings?
StockStory74d agoneutral
B&G Foods (BGS): Buy, Sell, or Hold Post Q1 Earnings?

Over the past six months, B&G Foods’s shares (currently trading at $4.09) have posted a disappointing 12.2% loss, well below the S&P 500’s 10.9% gain. This might have investors contemplating their next move.

3 Reasons to Sell FLG and 1 Stock to Buy Instead
StockStory74d agoneutral
3 Reasons to Sell FLG and 1 Stock to Buy Instead

Flagstar Financial has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 13.3% to $14.06 per share while the index has gained 10.9%.

3 Reasons GH is Risky and 1 Stock to Buy Instead
StockStory74d agobullish
3 Reasons GH is Risky and 1 Stock to Buy Instead

Over the past six months, Guardant Health has been a great trade, beating the S&P 500 by 11.7%. Its stock price has climbed to $129.08, representing a healthy 22.7% increase. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.